Vital KSK Holdings Incorporation operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vital KSK Holdings Incorporation with three other
drug stores in Asia:
Toho Holdings Company Limited
sales of 1.23 trillion Japanese Yen [US$11.07 billion]
Immuno-Biological Laboratories Company Limited
(741.53 million Japanese Yen [US$6.67 million]
Hokuyaku Takeyama Holdings, Inc
(228.71 billion Japanese Yen [US$2.06 billion]
Vital KSK Holdings Incorporation reported sales of ¥581.08 billion (US$5.22 billion)
March of 2017.
decrease of 6.4%
versus 2016, when the company's sales were ¥621.04 billion.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Vital KSK Holdings Incorporation had sales
of ¥541.65 billion.